FST and liver disorder: Activin-A and follistatin have been proposed as diagnostic/prognostic markers for a variety of liver diseases since pathological alterations in their serum concentrations, which correlated with the severity of the diseases, have been documented in several liver pathologies including viral hepatitis B and hepatitis C [20, 21].